Dow Up 1.13% Nasdaq Up 1.41%

Nymox Pharmaceutical Corporation (NYMX)

-NasdaqCM
5.14 Down 0.08(1.53%) 3:55PM EDT
Prev Close:5.22
Open:5.24
Bid:4.30 x 200
Ask:5.47 x 500
1y Target Est:10.11
Beta:0.89
Next Earnings Date:N/A
Day's Range:5.12 - 5.24
52wk Range:3.81 - 7.22
Volume:16,922
Avg Vol (3m):88,850
Market Cap:181.96M
P/E (ttm):N/A
EPS (ttm):-0.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NYMXDown 1.53%181.96M
ABTUp 0.23%65.55B
LHUp 1.77%9.28B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):58.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nymox Pharmaceutical Corporation, a biopharmaceutical company, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback